Investment Research & Advisory Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-600
| Closed | -$39.6K | – | 213 |
|
2024
Q3 | $39.6K | Hold |
600
| – | – | 0.02% | 107 |
|
2024
Q2 | $55.4K | Hold |
600
| – | – | 0.02% | 94 |
|
2024
Q1 | $57.3K | Hold |
600
| – | – | 0.03% | 96 |
|
2023
Q4 | $45.8K | Hold |
600
| – | – | 0.02% | 99 |
|
2023
Q3 | $41.6K | Hold |
600
| – | – | 0.02% | 101 |
|
2023
Q2 | $56.6K | Hold |
600
| – | – | 0.03% | 96 |
|
2023
Q1 | $49.6K | Hold |
600
| – | – | 0.03% | 94 |
|
2022
Q4 | $44.8K | Hold |
600
| – | – | 0.03% | 97 |
|
2022
Q3 | $50K | Hold |
600
| – | – | 0.04% | 93 |
|
2022
Q2 | $57K | Hold |
600
| – | – | 0.04% | 92 |
|
2022
Q1 | $71K | Hold |
600
| – | – | 0.04% | 98 |
|
2021
Q4 | $78K | Hold |
600
| – | – | 0.05% | 97 |
|
2021
Q3 | $68K | Hold |
600
| – | – | 0.04% | 93 |
|
2021
Q2 | $62K | Hold |
600
| – | – | 0.04% | 99 |
|
2021
Q1 | $50K | Hold |
600
| – | – | 0.04% | 99 |
|
2020
Q4 | $55K | Hold |
600
| – | – | 0.04% | 93 |
|
2020
Q3 | $48K | Hold |
600
| – | – | 0.04% | 97 |
|
2020
Q2 | $41K | Hold |
600
| – | – | 0.04% | 98 |
|
2020
Q1 | $38K | Hold |
600
| – | – | 0.04% | 93 |
|
2019
Q4 | $47K | Buy |
+600
| New | +$47K | 0.04% | 104 |
|